Literature DB >> 22116344

Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.

Anna-Maria A De Costa1, Corinne A Schuyler, David D Walker, M Rita I Young.   

Abstract

While studies have indicated that squamous cell carcinoma of the head and neck (HNSCC) is associated with immune suppression, these studies did not analyze the immune response at the dysplastic stage. The present study utilized a mouse model of 4-nitroquinoline 1-oxide-induced oral carcinogenesis to examine the alterations in immune phenotype at the premalignant and malignant stages of HNSCC. Cervical lymph nodes of HNSCC-bearing mice were found to contain a greater number of cells, including a greater number of conventional (Tconv) and regulatory (Treg) T cells, compared to cervical lymph nodes of control and premalignant lesion-bearing mice, though the Tconv cells appear to be less proliferative and the Treg cells appear to be less suppressive at the HNSCC stage. Premalignant lesion-bearing mouse lymph nodes consist of a greater percentage of Tconv cells expressing markers for activation, memory, and exhaustion compared to both control and HNSCC-bearing mice. Also, lymph nodes' cells from both premalignant lesion-bearing and HNSCC-bearing mice include increased levels of Th1, Tc1, and Th17 cells, with no differences in levels of Th2 cells, compared to control mice. The data show that while there is the expected increase in immunosuppressive Tregs in lymph nodes when HNSCC is present, there is also an unexpected increase in immune populations usually associated with a beneficial antitumor response, including Tconv cells and Th1 and Tc1 cells. In addition, the results demonstrate that the premalignant stage of HNSCC development is associated with a robust immune response involving an increase in inflammatory Th1, Tc1, and Th17 cells.

Entities:  

Mesh:

Year:  2011        PMID: 22116344      PMCID: PMC5925419          DOI: 10.1007/s00262-011-1154-8

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  37 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells.

Authors:  Sian M Henson; Ornella Franzese; Richard Macaulay; Valentina Libri; Rita I Azevedo; Sorena Kiani-Alikhan; Fiona J Plunkett; Joanne E Masters; Sarah Jackson; Stephen J Griffiths; Hans-Peter Pircher; Maria V D Soares; Arne N Akbar
Journal:  Blood       Date:  2009-04-30       Impact factor: 22.113

3.  Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells.

Authors:  M R Young; M A Wright; Y Lozano; M M Prechel; J Benefield; J P Leonetti; S L Collins; G J Petruzzelli
Journal:  Int J Cancer       Date:  1997-02-20       Impact factor: 7.396

4.  Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycle progression after PHA stimulation.

Authors:  T A Poulton; A Gallagher; R C Potts; J S Beck
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

Review 5.  Natural innate and adaptive immunity to cancer.

Authors:  Matthew D Vesely; Michael H Kershaw; Robert D Schreiber; Mark J Smyth
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

Review 6.  Th17 cells in cancer: help or hindrance?

Authors:  Cailin Moira Wilke; Ilona Kryczek; Shuang Wei; Ende Zhao; Ke Wu; Guobin Wang; Weiping Zou
Journal:  Carcinogenesis       Date:  2011-02-08       Impact factor: 4.944

7.  Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients.

Authors:  G N King; C M Healy; M T Glover; J T Kwan; D M Williams; I M Leigh; H V Worthington; M H Thornhill
Journal:  N Engl J Med       Date:  1995-04-20       Impact factor: 91.245

8.  Prognostic significance of tumor-infiltrating lymphocytes in oropharyngeal cancer.

Authors:  Samer Rajjoub; Suzanne R Basha; Eugene Einhorn; Marc C Cohen; Doug M Marvel; Duane A Sewell
Journal:  Ear Nose Throat J       Date:  2007-08       Impact factor: 1.697

9.  Tumor copromoting activity of gamma-interferon in the murine skin multistage carcinogenesis model.

Authors:  J J Reiners; T Rupp; A Colby; A R Cantu; A Pavone
Journal:  Cancer Res       Date:  1989-03-01       Impact factor: 12.701

10.  Long-term outcome and patterns of failure in patients with advanced head and neck cancer.

Authors:  Henrik Hauswald; Christian Simon; Simone Hecht; Juergen Debus; Katja Lindel
Journal:  Radiat Oncol       Date:  2011-06-10       Impact factor: 3.481

View more
  31 in total

1.  Premalignant Oral Lesion Cells Elicit Increased Cytokine Production and Activation of T-cells.

Authors:  Sara D Johnson; Corinne Levingston; M Rita I Young
Journal:  Anticancer Res       Date:  2016-07       Impact factor: 2.480

2.  Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.

Authors:  M Rita I Young; Corinne A Levingston; Sara D Johnson
Journal:  Int J Cancer       Date:  2016-01-28       Impact factor: 7.396

3.  DUSP1 phosphatase regulates the proinflammatory milieu in head and neck squamous cell carcinoma.

Authors:  Xiaoyi Zhang; J Madison Hyer; Hong Yu; Nisha J D'Silva; Keith L Kirkwood
Journal:  Cancer Res       Date:  2014-10-13       Impact factor: 12.701

Review 4.  T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma.

Authors:  Daniele Maggioni; Lorenzo Pignataro; Werner Garavello
Journal:  Oncoimmunology       Date:  2017-05-04       Impact factor: 8.110

5.  Administration of a vaccine composed of dendritic cells pulsed with premalignant oral lesion lysate to mice bearing carcinogen-induced premalignant oral lesions stimulates a protective immune response.

Authors:  Anna-Maria A De Costa; Danielle N Justis; Corinne A Schuyler; M Rita I Young
Journal:  Int Immunopharmacol       Date:  2012-05-16       Impact factor: 4.932

Review 6.  Lessons learned from SMAD4 loss in squamous cell carcinomas.

Authors:  Ariel L Hernandez; Christian D Young; Jing H Wang; Xiao-Jing Wang
Journal:  Mol Carcinog       Date:  2019-05-29       Impact factor: 4.784

Review 7.  Immunomethylomics: A Novel Cancer Risk Prediction Tool.

Authors:  Karl T Kelsey; John K Wiencke
Journal:  Ann Am Thorac Soc       Date:  2018-04

8.  Characterization of the tumor immune micromilieu and its interference with outcome after concurrent chemoradiation in patients with oropharyngeal carcinomas.

Authors:  Anne-Kathrin Hess; Korinna Jöhrens; Andre Zakarneh; Panagiotis Balermpas; Jens Von Der Grün; Claus Rödel; Wilko Weichert; Michael Hummel; Ulrich Keilholz; Volker Budach; Ingeborg Tinhofer
Journal:  Oncoimmunology       Date:  2019-05-25       Impact factor: 8.110

9.  Adipocytes as immune regulatory cells.

Authors:  Silvana A Vielma; Richard L Klein; Corinne A Levingston; M Rita I Young
Journal:  Int Immunopharmacol       Date:  2013-04-13       Impact factor: 4.932

10.  Premalignant lesions skew spleen cell responses to immune modulation by adipocytes.

Authors:  Silvana A Vielma; Richard L Klein; Corinne A Levingston; M Rita I Young
Journal:  Anticancer Res       Date:  2013-05       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.